LEP and metabolic dysfunction-associated steatotic liver disease: Previous studies suggested that inflammatory mediators such as lipocalin, leptin, and tumor necrosis factor-α secreted by adipocytes (34), especially lipocalin and leptin, could influence the development of NAFLD by regulating hepatic fat accumulation, IR, and fibrosis (35).